DE69125230D1 - Tricyclische Verbindungen enthaltende Salben - Google Patents

Tricyclische Verbindungen enthaltende Salben

Info

Publication number
DE69125230D1
DE69125230D1 DE69125230T DE69125230T DE69125230D1 DE 69125230 D1 DE69125230 D1 DE 69125230D1 DE 69125230 T DE69125230 T DE 69125230T DE 69125230 T DE69125230 T DE 69125230T DE 69125230 D1 DE69125230 D1 DE 69125230D1
Authority
DE
Germany
Prior art keywords
tricyclic compounds
ointments containing
containing tricyclic
ointment
octacos
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69125230T
Other languages
English (en)
Other versions
DE69125230T2 (de
Inventor
Sotoo Asakura
Yoshio Murakami
Nobuto Kanagawa
Toshiomi Nakate
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astellas Pharma Inc
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=16982211&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69125230(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Publication of DE69125230D1 publication Critical patent/DE69125230D1/de
Application granted granted Critical
Publication of DE69125230T2 publication Critical patent/DE69125230T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DE69125230T 1990-09-04 1991-08-30 Tricyclische Verbindungen enthaltende Salben Expired - Lifetime DE69125230T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP23517790 1990-09-04

Publications (2)

Publication Number Publication Date
DE69125230D1 true DE69125230D1 (de) 1997-04-24
DE69125230T2 DE69125230T2 (de) 1997-07-10

Family

ID=16982211

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69125230T Expired - Lifetime DE69125230T2 (de) 1990-09-04 1991-08-30 Tricyclische Verbindungen enthaltende Salben

Country Status (20)

Country Link
US (1) US5385907A (de)
EP (1) EP0474126B1 (de)
JP (1) JP2526752B2 (de)
KR (1) KR100194240B1 (de)
CN (1) CN1069193C (de)
AT (1) ATE150304T1 (de)
AU (1) AU656145B2 (de)
CA (1) CA2050623C (de)
DE (1) DE69125230T2 (de)
DK (1) DK0474126T3 (de)
ES (1) ES2099112T3 (de)
GR (1) GR3022883T3 (de)
HK (1) HK1000006A1 (de)
HU (2) HUT59002A (de)
IE (1) IE913085A1 (de)
PH (1) PH31282A (de)
PT (1) PT98862B (de)
RU (1) RU2079303C1 (de)
SG (1) SG46547A1 (de)
ZA (1) ZA916983B (de)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2134860T3 (es) * 1992-11-18 1999-10-16 Fujisawa Pharmaceutical Co Preparacion farmaceutica de accion prolongada.
JPH06345646A (ja) * 1993-06-08 1994-12-20 Fujisawa Pharmaceut Co Ltd ローション剤
AU735106B2 (en) * 1994-10-26 2001-06-28 Novartis Ag Pharmaceutical compositions
DE19549794B4 (de) * 1994-10-26 2009-07-30 Novartis Ag Pharmazeutische Zusammensetzungen
GB2327611B (en) * 1994-10-26 1999-06-02 Novartis Ag Macrolide compositions
NZ295170A (en) * 1994-10-26 1999-02-25 Novartis Ag Topical pharmaceutical compositions comprising a fk506 class compound, an unsaturated fatty alcohol, water and diether alcohol, alkanediol or ether diol as a solvent
GB2327610B (en) * 1994-11-04 1999-06-02 Novartis Ag Macrolide compositions
AR004480A1 (es) * 1995-04-06 1998-12-16 Amico Derin C D Compuestos de ascomicina que poseen actividad antiinflamatoria, pro cedimiento para prepararlos, uso de dichos compuestos para preparar agentesfarmaceuticos y composiciones farmaceuticas que los incluyen
US5993787A (en) * 1996-09-13 1999-11-30 Johnson & Johnson Consumer Products, Inc. Composition base for topical therapeutic and cosmetic preparations
WO1998029136A1 (en) * 1996-12-27 1998-07-09 Takeda Chemical Industries, Ltd. Stabilized tricyclic compound
TW450810B (en) * 1997-02-20 2001-08-21 Fujisawa Pharmaceutical Co Macrolides antibiotic pharmaceutical composition for preventing and treating skin diseases
GB9723669D0 (en) * 1997-11-07 1998-01-07 Univ Aberdeen Skin penetration enhancing components
JP3732525B2 (ja) * 1998-04-27 2006-01-05 アステラス製薬株式会社 医薬組成物
GB9817064D0 (en) * 1998-08-05 1998-10-07 Fujisawa Pharmaceutical Co New use
US6300341B1 (en) 1998-09-30 2001-10-09 The Procter & Gamble Co. 2-substituted heterocyclic sulfonamides
US6307049B1 (en) 1998-09-30 2001-10-23 The Procter & Gamble Co. Heterocyclic 2-substituted ketoamides
GB9826656D0 (en) 1998-12-03 1999-01-27 Novartis Ag Organic compounds
AUPR529701A0 (en) * 2001-05-28 2001-06-21 Fujisawa Pharmaceutical Co., Ltd. Pharmaceutical composition
US7033604B2 (en) * 2001-07-06 2006-04-25 Sucampo Ag Composition for topical administration
AR038628A1 (es) * 2002-03-04 2005-01-19 Novartis Ag Composicion oftalmica
EP1531793A1 (de) * 2002-07-23 2005-05-25 Novartis AG Augensalbenzusammensetzung mit einem arzneimittel, einer salbengrundlage und einem l slichmachenden/dispergierenden mittel
GB0218996D0 (en) * 2002-08-14 2002-09-25 Novartis Ag Organic compounds
WO2006018024A2 (en) * 2004-08-18 2006-02-23 Ace Aps Cosmetic and pharmaceutical compositions comprising ace inhibitors and/or angiotensin ii receptor antagonists
CA2526419C (en) * 2005-01-04 2012-09-25 Texas United Chemical Company, Llc Compounded hydrocarbon oil and oil base drilling fluids prepared therefrom
CN101119730A (zh) * 2005-02-14 2008-02-06 大正制药株式会社 软膏剂
JPWO2006098353A1 (ja) * 2005-03-15 2008-08-28 協和醗酵工業株式会社 外用剤
PL1992622T3 (pl) 2006-02-21 2012-01-31 Eisai R&D Man Co Ltd Pochodna 4-(3-benzoiloaminofenylo)-6,7-dimetoksy-2-metyloaminochinazoliny
EP2123641A4 (de) 2007-02-16 2011-06-22 Eisai R&D Man Co Ltd Kristall, amorphe form und salt von methyl n-[3-(6,7-dimethoxy- 2-methylaminochinazolin-4-yl)phenyl]terephthalamsäure
US10265265B2 (en) 2007-03-15 2019-04-23 Drug Delivery Solutions Limited Topical composition
TWI414296B (zh) 2007-08-17 2013-11-11 Eisai R&D Man Co Ltd Innovative agents
AU2008290000B2 (en) 2007-08-17 2012-05-10 Eisai R & D Management Co., Ltd. Method for producing quinazoline derivative
WO2010041684A1 (ja) 2008-10-08 2010-04-15 高田製薬株式会社 タクロリムス外用剤
JP2010132607A (ja) * 2008-12-05 2010-06-17 Taisho Pharm Ind Ltd アトピー性皮膚炎治療用軟膏剤
JP2010202546A (ja) * 2009-03-02 2010-09-16 Taisho Pharm Ind Ltd アトピー性皮膚炎の治療用軟膏製剤
WO2012105521A1 (ja) * 2011-01-31 2012-08-09 国立大学法人大阪大学 皮膚疾患を処置するための外用薬およびその製造方法
CN102885761B (zh) * 2012-09-24 2015-08-05 浙江万晟药业有限公司 一种制备他克莫司软膏的方法
RU2538680C2 (ru) * 2013-03-12 2015-01-10 Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") Фармацевтическая композиция для лечения атопического дерматита и способ ее получения
RU2553600C2 (ru) * 2013-05-16 2015-06-20 Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") Фармацевтическая композиция для лечения заболеваний кожи
CN104127369A (zh) * 2014-07-02 2014-11-05 人福医药集团股份公司 他克莫司软膏及其制备方法
JPWO2016068208A1 (ja) 2014-10-28 2017-08-10 晃史 山口 妊娠状態を改善するための薬剤及びその利用
CN106309353A (zh) * 2015-06-19 2017-01-11 江苏吉贝尔药业股份有限公司 一种治疗银屑病的软膏剂及其制备方法
CN109069418A (zh) 2016-04-04 2018-12-21 药品配送方案有限公司 包含他克莫司的局部组合物
CN105769752B (zh) * 2016-04-08 2018-12-11 湖北人福成田药业有限公司 制备他克莫司软膏的方法及他克莫司软膏
EP3542788A1 (de) 2018-03-19 2019-09-25 MC2 Therapeutics Limited Topische zusammensetzung enthaltend calcipotriol und betamethason dipropionat
CN112533599A (zh) 2018-08-10 2021-03-19 山口晃史 与母体和胎儿的关系中的体液免疫相关的疾病的治疗药
WO2020117134A1 (en) 2018-12-04 2020-06-11 İlko İlaç Sanayi̇ Ve Ti̇caret A.Ş. Stable tacrolimus ointment formulation for topical treatment of skin conditions
US20220062245A1 (en) 2018-12-18 2022-03-03 Koushi Yamaguchi Agent for improving infertility, recurrent miscarriage, and state of pregnancy
CN114767688A (zh) * 2019-09-04 2022-07-22 武汉科福新药有限责任公司 透皮促渗组合物及其在噻吗洛尔制剂中的应用
CN116056687A (zh) * 2020-03-02 2023-05-02 上海奥科达医药科技股份有限公司 含有mtor抑制剂的外用制剂
CN112022798B (zh) * 2020-08-11 2022-04-29 四川大学华西医院 一种速效他克莫司软膏、制备方法及应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH677448A5 (de) * 1987-11-09 1991-05-31 Sandoz Ag
KR0159766B1 (ko) * 1989-10-16 1998-12-01 후지사와 토모키치로 양모제 조성물
US5061700A (en) * 1989-11-16 1991-10-29 Gordon Jay Dow Glyceryl acetate ointment vehicles

Also Published As

Publication number Publication date
RU2079303C1 (ru) 1997-05-20
AU8351591A (en) 1992-03-12
GR3022883T3 (en) 1997-06-30
JP2526752B2 (ja) 1996-08-21
ZA916983B (en) 1992-05-27
AU656145B2 (en) 1995-01-27
HK1000006A1 (en) 1997-10-03
CA2050623A1 (en) 1992-03-05
CN1059468A (zh) 1992-03-18
US5385907A (en) 1995-01-31
DK0474126T3 (de) 1997-04-07
CA2050623C (en) 2002-02-05
IE913085A1 (en) 1992-03-11
JPH0517481A (ja) 1993-01-26
KR920005987A (ko) 1992-04-27
ES2099112T3 (es) 1997-05-16
SG46547A1 (en) 1998-02-20
EP0474126A1 (de) 1992-03-11
DE69125230T2 (de) 1997-07-10
CN1069193C (zh) 2001-08-08
KR100194240B1 (ko) 1999-06-15
PT98862A (pt) 1992-08-31
EP0474126B1 (de) 1997-03-19
HU211470A9 (en) 1995-11-28
ATE150304T1 (de) 1997-04-15
HUT59002A (en) 1992-04-28
PT98862B (pt) 1999-02-26
PH31282A (en) 1998-07-06

Similar Documents

Publication Publication Date Title
ATE150304T1 (de) Tricyclische verbindungen enthaltende salben
ATE112486T1 (de) Trizyklische verbindungen enthaltende suspensionen.
DE3777223D1 (de) Feste dispersion der substanz fr-900506.
ES2134860T3 (es) Preparacion farmaceutica de accion prolongada.
DK0406791T3 (da) Vandigt flydende præparat til ekstern anvendelse
ES2068312T3 (es) Formulaciones liquidas acuosas.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: ASTELLAS PHARMA INC., TOKIO/TOKYO, JP